Posts With Tag Enhertu

Discover the pivotal findings from AstraZeneca's DESTINY-Breast09 trial, showcasing Enhertu's potential in HER2-positive metastatic breast cancer and its impact on patient care.

Explore AstraZeneca's Enhertu approval in the EU for HER2-low breast cancer, backed by significant trial success and a commitment to revolutionizing treatment options.